Bio-Techne (TECH) Current Taxes (2010 - 2026)
Bio-Techne's quarterly Current Taxes came in at $3.0 million in Q1 2026, down 18.11% year-on-year from $3.6 million in Q1 2025, and up 19.99% quarter-over-quarter from $2.5 million in Q4 2025.
Bio-Techne has reported Current Taxes for 17 years, with the latest figure at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes fell 18.11% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 18.11% YoY), and the FY2025 full-year result was $10.8 million, up 190.61% from the prior year.
- Current Taxes for Q1 2026 stood at $3.0 million, up from $2.5 million in the prior quarter.
- The five-year high for Current Taxes was $25.3 million in Q4 2022, with the low at $2.5 million in Q4 2025.
- Average Current Taxes over 5 years is $9.0 million, with a median of $6.6 million recorded in 2023.
- Year-over-year, Current Taxes sank 73.71% in 2023 and surged 190.61% in 2025.
- Tracing TECH's Current Taxes over 5 years: stood at $25.3 million in 2022, then slumped by 73.71% to $6.6 million in 2023, then plunged by 52.74% to $3.1 million in 2024, then slipped by 21.17% to $2.5 million in 2025, then gained by 19.99% to $3.0 million in 2026.
- The last three Current Taxes figures came in at $3.0 million (Q1 2026), $2.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.97 Mn |
| Dec 31, 2025 | 2.48 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 10.77 Mn |
| Mar 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 12.08 Mn |
| Dec 31, 2023 | 6.65 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 12.02 Mn |
| Mar 31, 2023 | 18.17 Mn |
| Dec 31, 2022 | 25.28 Mn |
| Sep 30, 2022 | 17.27 Mn |
| Jun 30, 2022 | 13.24 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | 14.28 Mn |
| Sep 30, 2021 | 6.51 Mn |
| Jun 30, 2021 | 5.34 Mn |
| Mar 31, 2021 | 3.56 Mn |
| Dec 31, 2020 | 3.66 Mn |
| Sep 30, 2020 | 2.16 Mn |
| Jun 30, 2020 | 2.38 Mn |
| Mar 31, 2020 | 10.38 Mn |
| Dec 31, 2019 | 12.85 Mn |
| Sep 30, 2019 | 6.53 Mn |
| Jun 30, 2019 | 5.76 Mn |
| Mar 31, 2019 | 5.32 Mn |
| Dec 31, 2018 | 4.98 Mn |
| Sep 30, 2018 | 5.23 Mn |
| Jun 30, 2018 | 8.88 Mn |
| Mar 31, 2018 | 6.41 Mn |
| Dec 31, 2017 | 300,000.00 |
| Sep 30, 2017 | 3.50 Mn |
| Jun 30, 2017 | 2.48 Mn |
| Mar 31, 2017 | 1.92 Mn |
| Sep 30, 2016 | 4.65 Mn |
| Jun 30, 2016 | 1.78 Mn |
| Mar 31, 2016 | 3.95 Mn |
| Dec 31, 2015 | 852,000.00 |
| Sep 30, 2015 | 8.44 Mn |
| Jun 30, 2015 | 1.97 Mn |
| Mar 31, 2015 | 2.02 Mn |
| Dec 31, 2014 | 4.00 Mn |
| Sep 30, 2014 | 1.98 Mn |
| Jun 30, 2014 | 496,000.00 |
| Mar 31, 2014 | 5.68 Mn |
| Dec 31, 2013 | 1.82 Mn |
| Sep 30, 2013 | 2.97 Mn |
| Jun 30, 2013 | 2.28 Mn |
| Mar 31, 2013 | 4.18 Mn |
| Dec 31, 2012 | 2.28 Mn |
| Sep 30, 2012 | 2.55 Mn |
| Jun 30, 2012 | 3.25 Mn |
| Mar 31, 2012 | 4.48 Mn |
| Dec 31, 2011 | 967,000.00 |
| Sep 30, 2011 | 3.96 Mn |
| Jun 30, 2011 | 5.51 Mn |
| Mar 31, 2011 | 4.10 Mn |
| Dec 31, 2010 | 4.22 Mn |
| Sep 30, 2010 | 4.14 Mn |
| Jun 30, 2010 | 3.64 Mn |